Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban and aspirin after CABG surgery
NCT06019741Phase 4Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in atherothrombosis, sponsored by Shiraz University of Medical Sciences. Started Feb 2021; status: completed.
02
Drugs
rivaroxaban
03
Conditions
atherothrombosis
Beyond the preview
Go deeper on NCT06019741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06019741.